Gilead Sciences Inc

Founded in 1987 Gilead Sciences is one of the leaders in the discovery and development of a new class of human therapeutics based on nucleotides the building blocks of DNA and RNA in the United States The company discovers develops and commercializes medications to advance the care of patients suffering from lifethreatening diseases Headquartered in Foster City Calif it serves North America Europe and Australia and employs a staff of more than 3400 individuals Gilead Sciences areas of focus include antivirals such as HIVAIDS and chronic hepatitis as well as cardiovascular conditions including pulmonary arterial hypertension and resistant hypertension The company also conducts studies on various respiratory diseases such as influenza and cystic fibrosis

Gilead Sciences Inc, founded in 1987, is a leading name in the discovery and development of nucleotide-based human therapeutics—medications built on the same building blocks as DNA and RNA. The company discovers, develops, and commercializes medicines designed to advance care for patients facing life-threatening diseases. Based in Foster City, California, Gilead serves markets across North America, Europe, and Australia, with a workforce of more than 3,400 professionals. In the Seattle, Washington area, Gilead’s focus areas include antivirals such as HIV/AIDS and chronic hepatitis, cardiovascular conditions including pulmonary arterial hypertension and resistant hypertension, and research into respiratory diseases such as influenza and cystic fibrosis. Known for its translational approach to therapeutic development and deep expertise in nucleotide-based drug discovery, Gilead supports ongoing study and advancement of treatments in high-impact therapeutic areas where clinical progress matters most.